Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
Article
oleh
Jennifer C E Lane
,
James Weaver
,
Kristin Kostka
,
Talita Duarte-Salles
,
Maria Tereza F Abrahao
,
Heba Alghoul
,
Osaid Alser
,
Thamir M Alshammari
,
Patricia Biedermann
,
Juan M Banda
,
Edward Burn
,
Paula Casajust
,
Mitchell M Conover
,
Aedin C Culhane
,
Alexander Davydov
,
Scott L DuVall
,
Dmitry Dymshyts
,
Sergio Fernandez-Bertolin
,
Kristina Fišter
,
Jill Hardin
,
Laura Hester
,
George Hripcsak
,
Benjamin Skov Kaas-Hansen
,
Seamus Kent
,
Sajan Khosla
,
Spyros Kolovos
,
Christophe G Lambert
,
Johan van der Lei
,
Kristine E Lynch
,
Rupa Makadia
,
Andrea V Margulis
,
Michael E Matheny
,
Paras Mehta
,
Daniel R Morales
,
Henry Morgan-Stewart
,
Mees Mosseveld
,
Danielle Newby
,
Fredrik Nyberg
,
Anna Ostropolets
,
Rae Woong Park
,
Albert Prats-Uribe
,
Gowtham A Rao
,
Christian Reich
,
Jenna Reps
,
Peter Rijnbeek
,
Selva Muthu Kumaran Sathappan
,
Martijn Schuemie
,
Sarah Seager
,
Anthony G Sena
,
Azza Shoaibi
,
Matthew Spotnitz
,
Marc A Suchard
,
Carmen O Torre
,
David Vizcaya
,
Haini Wen
,
Marcel de Wilde
,
Junqing Xie
,
Seng Chan You
,
Lin Zhang
,
Oleg Zhuk
,
Patrick Ryan
,
Daniel Prieto-Alhambra
,
OHDSI-COVID-19 consortium
Terbitan |
: 2020 |
Institusi |
:
DEFAULT |
Gedung |
:
|